Neurocrine Biosciences, Inc.【NBIX】 総負債の推移
機能の使い方
|
（単位：百万ドル）
|
総負債
|
前年比（％）
|
|
4Q25
|
1,378
|
+22.1%
|
|
3Q25
|
1,262
|
+54.7%
|
|
2Q25
|
1,195
|
+50.2%
|
|
1Q25
|
1,152
|
+6.0%
|
|
4Q24
|
1,129
|
+10.8%
|
|
3Q24
|
816
|
-3.5%
|
|
2Q24
|
795
|
+4.7%
|
|
1Q24
|
1,086
|
+60.9%
|
|
4Q23
|
1,019
|
+54.2%
|
|
3Q23
|
846
|
+41.3%
|
|
2Q23
|
760
|
+30.5%
|
|
1Q23
|
675
|
-10.4%
|
|
4Q22
|
660
|
-5.4%
|
|
3Q22
|
598
|
-10.8%
|
|
2Q22
|
582
|
-14.0%
|
|
1Q22
|
753
|
+17.6%
|
|
4Q21
|
698
|
+14.8%
|
|
3Q21
|
671
|
-3.9%
|
|
2Q21
|
677
|
-1.1%
|
|
1Q21
|
640
|
-3.1%
|
|
4Q20
|
608
|
-9.1%
|
|
3Q20
|
698
|
+15.3%
|
|
2Q20
|
684
|
+17.4%
|
|
1Q20
|
661
|
+20.6%
|
|
4Q19
|
669
|
+30.6%
|
|
3Q19
|
605
|
+24.5%
|
|
2Q19
|
583
|
+25.7%
|
|
1Q19
|
548
|
+24.1%
|
|
4Q18
|
512
|
+15.0%
|
|
3Q18
|
486
|
+14.4%
|
|
2Q18
|
463
|
+13.5%
|
|
1Q18
|
441
|
+946.5%
|
|
4Q17
|
445
|
+787.2%
|
|
3Q17
|
424
|
+794.5%
|
|
2Q17
|
408
|
+737.8%
|
|
1Q17
|
42
|
-8.9%
|
|
4Q16
|
50
|
-0.2%
|
|
3Q16
|
47
|
+4.4%
|
|
2Q16
|
48
|
+10.2%
|
|
1Q16
|
46
|
+7.7%
|
|
4Q15
|
50
|
+46.6%
|
|
3Q15
|
45
|
+34.9%
|
|
2Q15
|
44
|
+35.4%
|
|
1Q15
|
43
|
+33.5%
|
|
4Q14
|
34
|
+0.2%
|
|
3Q14
|
33
|
-8.1%
|
|
2Q14
|
32
|
-15.7%
|
|
1Q14
|
32
|
-17.3%
|
|
4Q13
|
34
|
-17.6%
|
|
3Q13
|
36
|
-26.6%
|
|
2Q13
|
38
|
-32.4%
|
|
1Q13
|
38
|
-41.2%
|
|
4Q12
|
41
|
-46.9%
|
|
3Q12
|
49
|
-45.3%
|
|
2Q12
|
57
|
-43.7%
|
|
1Q12
|
66
|
-
|
|
4Q11
|
78
|
-
|
|
3Q11
|
91
|
-
|
|
2Q11
|
101
|
-
|